Segui
Rita A Sakr
Rita A Sakr
MD, PhD / MSKCC
Email verificata su mskcc.org
Titolo
Citata da
Citata da
Anno
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
W Toy, Y Shen, H Won, B Green, RA Sakr, M Will, Z Li, K Gala, S Fanning, ...
Nature genetics 45 (12), 1439-1445, 2013
10102013
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) Tumor Pathology iná…
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer epidemiology, biomarkers & prevention 21 (1), 134-147, 2012
6202012
Clinical management factors contribute to the decision for contralateral prophylactic mastectomy
TA King, R Sakr, S Patil, I Gurevich, M Stempel, M Sampson, M Morrow
Journal of Clinical Oncology 29 (16), 2158-2164, 2011
3272011
Progression from ductal carcinoma in situ to invasive breast cancer: revisited
CF Cowell, B Weigelt, RA Sakr, CKY Ng, J Hicks, TA King, JS Reis-Filho
Molecular oncology 7 (5), 859-869, 2013
2962013
Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast CancerPI3K/AKT Activation in Trastuzumab Resistance
S Chandarlapaty, RA Sakr, D Giri, S Patil, A Heguy, M Morrow, S Modi, ...
Clinical Cancer Research 18 (24), 6784-6791, 2012
1882012
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
1872014
Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk
TA King, M Pilewskie, S Muhsen, S Patil, SK Mautner, A Park, S Oskar, ...
Journal of clinical oncology 33 (33), 3945, 2015
1542015
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
M Janiszewska, L Liu, V Almendro, Y Kuang, C Paweletz, RA Sakr, ...
Nature genetics 47 (10), 1212-1219, 2015
1532015
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiersá…
AM Mulligan, FJ Couch, D Barrowdale, SM Domchek, D Eccles, ...
Breast Cancer Research 13 (6), 1-20, 2011
1302011
The Genomic Landscape of Male Breast CancersMale Breast Cancer: Genomic Profiling
S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ...
Clinical Cancer Research 22 (16), 4045-4056, 2016
1292016
Genomic Complexity and AKT Dependence in Serous Ovarian CancerGenomics and AKT in Ovarian Cancer
AJ Hanrahan, N Schultz, ML Westfal, RA Sakr, DD Giri, S Scarperi, ...
Cancer discovery 2 (1), 56-67, 2012
1132012
Ductal carcinoma in situ: value of sentinel lymph node biopsy
R Sakr, E Barranger, M Antoine, H Prugnolle, E Dara´, S Uzan
Journal of surgical oncology 94 (5), 426-430, 2006
932006
Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma
RA Sakr, V Barbashina, M Morrogh, S Chandarlapaty, VP Andrade, ...
Applied immunohistochemistry & molecular morphology: AIMM/officialá…, 2010
692010
Risk of breast cancer associated with papilloma
R Sakr, R Rouzier, C Salem, M Antoine, J Chopier, E Darai, S Uzan
European Journal of Surgical Oncology (EJSO) 34 (12), 1304-1308, 2008
692008
Cadherin–catenin complex dissociation in lobular neoplasia of the breast
M Morrogh, VP Andrade, D Giri, RA Sakr, W Paik, LX Qin, CD Arroyo, ...
Breast cancer research and treatment 132 (2), 641-652, 2012
562012
Is there a role for routine screening MRI in women with LCIS?
TA King, S Muhsen, S Patil, S Koslow, S Oskar, A Park, M Morrogh, ...
Breast cancer research and treatment 142 (2), 445-453, 2013
532013
Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma
R Sakr, M Antoine, E Barranger, G Dubernard, C Salem, E Darai, S Uzan
The Breast Journal 14 (1), 55-60, 2008
512008
Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations
E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ...
The Journal of pathology 238 (5), 677-688, 2016
502016
PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast CarcinomaPI3K Pathway in DCIS
RA Sakr, B Weigelt, S Chandarlapaty, VP Andrade, E Guerini-Rocco, ...
Clinical Cancer Research 20 (9), 2326-2337, 2014
492014
The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and forá…
R Sakr, C Bezu, I Raoust, M Antoine, F Ettore, J Darcourt, K Kerrou, ...
International journal of clinical practice 62 (11), 1730-1735, 2008
492008
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20